Natus Executive and Leadership Team

Chris Landon, the Chief Executive Officer at Natus, directs the overarching corporate vision and long-term growth strategy for the organization. By aligning internal resources with the evolving needs of the global medical device market, Landon ensures the company maintains a competitive edge in newborn care and neurological diagnostics. This leadership role involves constant collaboration with the Board to refine product development roadmaps and expand market reach across international territories. Chris Landon monitors the performance of all business units to guarantee operational excellence and financial health. Through the implementation of rigorous quality standards, the Chief Executive Officer fosters a culture of innovation that directly supports the diagnosis and treatment of patients with central nervous system disorders. Ultimately, Landon drives the strategic initiatives that solidify the company position as a leader in sensory system medical technology.

Timothy Allen, the Chief Financial Officer at Natus, manages the fiscal health and capital allocation strategies required to support global medical device manufacturing. Overseeing financial planning, reporting, and risk management, Allen ensures the company maintains the liquidity necessary for ongoing research and development investments. This leadership role involves analyzing market data to optimize revenue streams across the newborn care and hearing impairment segments. Timothy Allen collaborates with executive leadership to align budgetary priorities with the broader corporate mission of improving patient diagnostics. By implementing robust financial controls, the Chief Financial Officer drives operational efficiency and long-term shareholder value. Through the oversight of global fiscal operations, Allen provides the economic stability required for the company to expand its footprint in the treatment of complex neurological and sensory system disorders.

Michael Owens, the Chief Technology Officer at Natus, architects the technical framework for next-generation medical devices used in epilepsy and sleep disorder monitoring. Overseeing the research and development pipeline, Owens ensures that engineering teams integrate advanced diagnostic capabilities into every product line. This role requires close coordination with clinical experts to translate complex neurological data into actionable insights for healthcare professionals. Michael Owens manages the intellectual property portfolio and drives the adoption of emerging technologies to enhance patient outcomes. By prioritizing scalable software and hardware solutions, the Chief Technology Officer maintains the technical superiority of the company product suite. Through continuous evaluation of industry trends, Owens secures the technological foundation necessary for sustained innovation in the competitive landscape of neurosurgical and neuromuscular disease treatment.

Linda Quinlivan, the Vice President, Strategy & Chief Marketing Officer, Clinical Affairs at Natus, directs the commercial strategy and clinical messaging for the entire product portfolio. Overseeing the alignment between clinical research and market positioning, Quinlivan ensures that healthcare providers understand the diagnostic value of company solutions in newborn care and neurology. This role involves managing global marketing campaigns that highlight the efficacy of medical devices in treating hearing impairment and neuromuscular diseases. Linda Quinlivan collaborates with the sales and product teams to penetrate new markets and strengthen existing customer relationships. By translating clinical data into compelling market narratives, the Vice President, Strategy & Chief Marketing Officer, Clinical Affairs drives brand awareness and product adoption. Through strategic oversight of clinical affairs, Quinlivan ensures that all marketing initiatives remain grounded in scientific evidence and patient-centric outcomes.

Nathan Rucker, the Chief Operations Officer at Natus, executes the manufacturing and supply chain strategies that deliver medical devices to healthcare facilities worldwide. Overseeing the production lifecycle, Rucker ensures that all equipment for epilepsy, sleep disorders, and newborn care meets stringent regulatory and quality standards. This leadership role involves optimizing logistics and procurement processes to maintain consistent product availability across diverse geographic regions. Nathan Rucker collaborates with the technology and finance teams to streamline production costs while maintaining high performance levels. By driving continuous improvement initiatives within the manufacturing plants, the Chief Operations Officer enhances operational throughput and reliability. Through the management of global supply chain networks, Rucker ensures that the company maintains the capacity to meet the growing demand for advanced neurological and neurosurgical treatment solutions.